Welcome to our dedicated page for ARHH news (Ticker: ARHH), a resource for investors and traders seeking the latest updates and insights on ARHH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ARHH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ARHH's position in the market.
Assure Holdings Corp. (OTCQB: ARHH) has signed an agreement with Aetna Colorado effective May 1, 2021. This allows Assure to provide intraoperative neuromonitoring (IONM) services as an in-network provider, streamlining billing and collections with contracted rates and timely claims payment. The partnership is viewed as strategic, potentially expanding beyond Colorado. Assure's compliance with medical necessity and dispute resolution strengthens its operational framework. This agreement may reduce financial risk and enhance revenue stability as the company expands its network.
Assure Holdings Corp. (OTCQB: ARHH) has appointed John Flood to its board of directors, bringing over 35 years of capital markets experience. Flood's background includes leadership at Craig-Hallum Capital Group, where he co-founded and served as chairman until retirement in 2019. His appointment aims to enhance the company's growth strategy in the intraoperative neuromonitoring (IONM) sector. Flood received 150,000 options to purchase shares at US$1.12 each, pending TSX Venture Exchange approval.
Assure Holdings Corp. (OTCQB: ARHH) has announced the acquisition of Elevation EP, LLC, effective March 15, 2021, as part of a strategic plan to enhance growth through mergers and acquisitions. Elevation, based in Texas, performed around 550 IONM procedures in 2020, primarily supported by commercial insurance. Assure aims to leverage Elevation's established relationships with surgeons to negotiate new agreements in Texas, potentially expanding its market share and operational capabilities in the region.
Assure Holdings Corp. (OTCQB: ARHH) has expanded into telemedicine by launching professional neurology services for intraoperative neuromonitoring (IONM) through its subsidiary. This shift aims to replace a third-party vendor, enhancing service quality control and negotiating power with payors. According to CEO John A. Farlinger, this move is pivotal for establishing Assure as a leader in the IONM sector, promising greater revenue potential and organic growth opportunities. The company has begun hiring for this new service and plans to expand offerings to other medical groups.
Assure Holdings Corp. (OTCQB: ARHH) is set to hold a conference call on March 26, 2021, at 12:00 p.m. ET to discuss its financial results for Q4 and the full year ending December 31, 2020. A press release with the financial details will precede the call. Interested parties can join via a toll-free number and access a live broadcast and replay through the provided links. Assure specializes in intraoperative neuromonitoring services, supporting surgical teams with a comprehensive suite of services and recognized high standards of patient care.
Assure Holdings (OTCQB: ARHH) announces the appointment of Dr. Isador Lieberman to its Medical Advisory Committee. Dr. Lieberman will leverage his expertise in orthopedic and spinal surgery to enhance Assure's intraoperative neuromonitoring (IONM) projects in collaboration with the Texas Back Institute. The company aims to improve clinical research in IONM, which is expected to support revenue cycle management and facilitate new in-network agreements. Dr. Lieberman brings extensive experience and innovation in spinal surgery and has a proven track record in clinical outcomes and research.
Assure Holdings Corp. (OTCQB: ARHH) announced it has received a $1,664,700 unsecured loan under the SBA's Paycheck Protection Program (PPP) to support its operations during the COVID-19 pandemic. The loan, which matures on February 25, 2026, carries a 1.0% interest rate and may be forgiven if employment levels are maintained and funds are used for eligible expenses. Additionally, Assure has engaged Contact Financial Corp. and KCSA Strategic Communications to enhance investor engagement and marketing efforts.
Assure Holdings has signed a Term Sheet to acquire Sentry Neuromonitoring for $3.5 million, comprising $1.225 million in cash and $2.275 million in common stock. This acquisition aims to increase Assure's procedural scale by approximately 50%, enhancing its market position in Texas and expanding into Missouri and Kansas. Sentry, established in 2007, performed over 5,500 procedures in 2020, primarily serving commercial insurance payors. The acquisition remains subject to several conditions, including due diligence and TSX approval.
Assure Holdings Corp. (OTCQB: ARHH) announced that its resale registration statement on Form S-1 was declared effective by the SEC on February 12, 2021. This statement allows for the resale of shares by selling shareholders under a registration rights agreement from a December 2020 private placement. Assure has become a reporting issuer under the Exchange Act and will file reports available at www.sec.gov. The company specializes in intraoperative neuromonitoring services for surgeries and is recognized for high patient care standards.
Assure Holdings Corp. (OTCQB: ARHH), a provider of intraoperative neuromonitoring services, will participate in several upcoming investor conferences in 2021. Key events include:
- MicroCap Rodeo Winter Wonderland Conference, February 16-19, with CEO John Farlinger presenting on February 17 at 1:00 PM ET.
- 33rd Annual ROTH Conference, March 15-17, where management will engage with investors.
- Planet MicroCap Showcase, April 20-22, featuring a presentation by Farlinger on April 21 at 1:00 PM ET.
For more information, visit assureneuromonitoring.com.
